02.25.21

Allergan Submits New Drug Application for Investigational Eye Drop for the Treatment of Presbyopia

Source: Allergan

02.18.21

Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia

Source: Ocuphire Pharma

01.20.21

Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol

12.16.20

Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopia

Source: Eyenovia

11.12.20

Adaptilens Announces $1.6 Million in Seed Funding for Development of Accommodating IOL

Source: Adaptilens

11.05.20

Staar Surgical Begins Commercialization of EVO Viva Presbyopia Correcting Lens

Source: Staar Surgical

10.28.20

Allergan Announces Positive Phase 3 Topline Results for Investigational Eye Drop for the Treatment of Presbyopia

Source: Allergan

10.06.20

UH Professor Developing New Technology to Detect Lens Elasticity Associated With Presbyopia

Source: University of Houston

10.02.20

Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for Presbyopia

Source: Orasis Pharmaceuticals

09.30.20

Biotech Healthcare Launches Optiflex TRIO Trifocal IOL in Europe

Source: Biotech Healthcare

View more stories